In invasive breast carcinoma patients, tumors with OR2B6 or OR2W3 upregulation possessed comparable numbers of TNBC, HER2-positive, and ER-positive, different than their corresponding groups in breast cancer cell lines. This evidence concerns the gene ESR1 and invasive breast carcinoma.